世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

バイオバンキング市場レポート：2025-2035

バイオバンキング市場レポート：2025-2035


Biobanking Market Report 2025-2035

概要 バイオバンキング市場レポート 2025-2035年 （米国貿易関税の影響を含む）： 本レポートは、新たな収益の柱を目指す大手企業にとって、業界とその根底にあるダイナミクスをより深く理解する上で... もっと見る

　

　

出版社 出版年月 電子版価格 納期 ページ数 言語
Visiongain
ヴィジョンゲイン社 		2025年11月20日 GBP5,150
部署ライセンス
ライセンス・価格情報
注文方法はこちら 		2営業日程度 355 英語

※上記価格は部署ライセンス（Departmental licence）価格です。
その他の価格についてはデータリソースまでお問合せください。
日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


　

サマリー

概要

バイオバンキング市場レポート 2025-2035年（米国貿易関税の影響を含む）： 本レポートは、新たな収益の柱を目指す大手企業にとって、業界とその根底にあるダイナミクスをより深く理解する上で貴重なものとなるでしょう。異業種への進出や、新たな地域での既存事業の拡大を希望する企業にとっても有用であろう。

マルチオミックスとAI統合が牽引する市場成長の加速

2025年に831億米ドル、2035年には1,940億米ドルに達すると予測される世界のバイオバンク市場は、従来のサンプル保存から大規模でデータリッチなマルチオミクスやAIを活用した研究インフラへの移行に伴い加速している。歴史的にバイオバンクは限られたアカデミック・リポジトリが中心であったが、現在では臨床、ゲノム、プロテオミクスのデータセットにリンクされた数百万の高品質サンプルを管理するグローバルに相互接続されたプラットフォームへと進化している。この変革は、シーケンシング、バイオマーカー探索、医薬品開発、トランスレーショナル・メディシンにおける生物試料の積極的活用に向けた、より広範な業界のシフトを反映している。

何十万ものサンプルを含む高度なプロテオミクスマッピングのような大規模な国家的・組織的イニシアチブは、このセクターの役割が拡大していることを示している。特に、2025年1月13日、イルミナは、deCODE Genetics、Standard BioTools、Tecan、GSK、Johnson & Johnson、Novartisとともに、次世代イルミナプロテオミクスプラットフォームを活用し、英国バイオバンク50,000サンプルを分析するプロテオミクスパイロットプログラムを発表した。このような共同研究は、最新のバイオバンクがいかに精密医療、疾病リスク分析、長期的な集団健康研究の重要な原動力となりつつあるかを浮き彫りにし、市場の堅調な拡大を牽引しています。

米国の貿易関税が世界のバイオバンク市場に与える影響とは？

米国の貿易関税は、特に輸入される超低温フリーザー、極低温システム、自動化モジュール、消耗品、LIMS関連ハードウェアなど、バイオバンクのバリューチェーン全体のコスト構造に上昇圧力をかけている。このようなコスト上昇により、バイオバンクは予算の安定性を維持するため、調達を見直し、地域のサプライヤーや関税免除のサプライヤーにシフトすることを余儀なくされている。関税はまた、インフラのアップグレードを遅らせ、拡張スケジュールを遅らせ、高度な自動化とデジタル化プロジェクトのための資本配分を制約している。これに対応するため、グローバル・サプライヤーは製造拠点の再編を進め、サービス・プロバイダーはコスト上昇を相殺するため、保管と加工の価格設定を調整している。全体として、関税環境は、バイオバンキング部門全体で、ローカライゼーション、マルチベンダー調達、財政的に規律ある業務計画への傾向を加速させている。

市場調査レポートを購入する前にすべき質問とは？

  • バイオバンク市場はどのように進化しているのか？
  • 何がバイオバンク市場を牽引し、阻害しているのか？
  • バイオバンキングの各サブマーケットは予測期間中にどのように成長し、2035年にはどれくらいの売上を占めるようになるのか？
  • 2025年から2035年にかけて、バイオバンキングの各サブマーケットの市場シェアはどのように推移するのか？
  • 2025年から2035年にかけて、市場全体を牽引する主な要因は何か？
  • 主要なバイオバンキング市場はマクロ経済の動きに幅広く追随するのだろうか、それとも個々の国の市場が他を凌駕するのだろうか？
  • 2035年までに各国市場のシェアはどのように変化し、どの地域が2035年の市場をリードするのか。
  • 主要プレーヤーと予測期間中の見通しは？
  • これらの大手企業のバイオバンキング・プロジェクトとは？
  • 2025年から2035年にかけて、業界はどのように進化するのか？その影響は？
  • 現在、そして今後10年間に行われるバイオバンキング・プロジェクトは？
  • バイオバンキング市場をさらに拡大するために、製品化の必要性は高まっているのか？
  • バイオバンキング市場はどこに向かっているのか、また、どのようにすれば市場の最前線に立つことができるのか。
  • 新商品や新サービスに最適な投資方法とは？
  • 企業を新たな成長軌道に乗せ、C-suiteに移行させるための重要な展望とは？

このことが、現在、そして今後10年間のバイオバンキング市場にどのような影響を与えるかを見極める必要がある：

  • 355ページに及ぶレポートには、121の表と182の図表が掲載されている。
  • について本レポートでは、業界の主要な有利分野を取り上げている。今すぐ
  • 世界、地域、国の売上高と成長に関する詳細な分析が含まれている。
  • 競合他社が成功した主なトレンド、変化、収益予測をハイライトします。

2035年までの予測やその他の分析から、商業的な展望が見えてきた

  • 2035年までの収益予測に加え、最新の実績、成長率、市場シェアもご覧いただけます。
  • ビジネスの展望や展開など、独自の分析が掲載されている。
  • 定性的分析（市場ダイナミクス、促進要因、機会、阻害要因など）、ポーターのファイブフォース分析、PEST分析、最近の動向をご覧いただけます。

レポート対象セグメント

製品とサービス

  • 機器

 -保管機器
 -検体分析機器
 -検体処理機器
 -検体輸送機器

  • 消耗品

 -保管消耗品
 -分析消耗品
 -処理消耗品
 -回収消耗品

  •  サービス

 -保管サービス
 -処理サービス
 -輸送サービス
 -供給サービス
 ソフトウェア

収納タイプ

  • 自動ストレージ
  • 手動ストレージ

所有権

  • 国内/地域機関
  • 大学
  • 非営利
  • プライベート

サンプル

  • 血液製剤
  • ヒト組織
  • 核酸
  • 細胞ライン
  • 生物流体

用途

  • 再生医療
  • 生命科学研究
  • 臨床研究

エンドユーザー

  • 製薬・バイオテクノロジー企業
  • CRO
  • 学術・研究機関
  • 病院

世界市場全体と各分野の売上予測に加え、5つの地域と26の主要国市場の売上予測も掲載しています：

北米

  • 米国
  • カナダ

欧州

  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • ロシア
  • オランダ
  • スイス
  • その他の欧州地域

アジア太平洋

  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • 東南アジア
  • その他のアジア太平洋地域

ラテンアメリカ

  • ブラジル
  • メキシコ
  • アルゼンチン
  • コロンビア
  • その他のラテンアメリカ地域

MEA

  • GCC
  • 南アフリカ
  • その他のMEA地域

Biobanking Market Report 2025-2035

また、2025年から2035年までのバイオバンキング市場における主要企業のプロファイルも掲載している。

主要企業と市場成長の可能性

  • ASKION GmbH
  • Avantor, Inc.
  • Azenta Inc.
  • BD
  • BioIVT
  • Boca Biolistics
  • Charles River Laboratories International, Inc.
  • Cryoport, Inc.
  • CTIBiotech
  • Hamilton Company
  • ISENET
  • Labcorp
  • Merck KGaA
  • PHC Holdings Corporation
  • ProteoGenex Inc.
  • QIAGEN
  • SciSafe
  • STEMCELL Technologies
  • Tecan Trading AG
  • Thermo Fisher Scientific Inc.
  • US Biolab Corporation

2025年から2035年までのバイオバンキング市場全体の世界売上高（金額ベース）は、2025年に800億米ドルを突破する。2035年まで力強い収益成長を予測。当研究所では、最大の可能性を秘めた組織を特定しています。各組織の能力、進捗状況、商業的展望を明らかにし、貴社が一歩先を行くための一助とします。

バイオバンキング市場、2025-2035年レポートはどのように役立つのか？

要約すると、350ページを超えるこのレポートは、以下の知識を提供する：

  • バイオバンキング市場の2025年から2035年までの収益予測、タイプ別・フェーズ別予測、世界・地域レベルでの各予測 - 業界の展望を発見し、投資と収益に最も有利な場所を見つけることができます。
  • 5つの地域と26の主要国市場の2035年までの収益予測 - 北米、欧州、アジア太平洋、中南米、MEAのバイオバンキング市場の2025年から2035年までの予測をご覧ください。また、米国、カナダ、メキシコ、ブラジル、ドイツ、フランス、英国、イタリア、中国、インド、日本、オーストラリアなどの主要国の市場も予測しています。
  • 2025年から2035年までのバイオバンキング市場に関わる主要企業22社の企業プロファイルを含む。

独自の予測による定量的・定性的分析をご覧ください。私たちのレポートだけに含まれる情報を入手し、貴重なビジネスインテリジェンスで情報を得ることができます。



ページTOPに戻る


目次

1 レポート概要
1.1 研究の目的
1.2 バイオバンキング市場の紹介
1.3 本レポートの内容
1.4 本レポートを読むべき理由
1.5 本分析レポートが回答する主な質問は以下の通り：
1.6 本レポートは誰のためのものか？
1.7 方法論
1.7.1 市場の定義
1.7.2 市場評価・予測手法
1.7.3 データの検証
1.7.3.1 一次調査
1.7.3.2 セカンダリーリサーチ
1.8 よくある質問（FAQ）
1.9 Visiongainの関連レポート
1.10 Visiongainについて

2 エグゼクティブ・サマリー

3 市場概要
3.1 主要な調査結果
3.2 市場ダイナミクス
3.2.1 市場促進要因
3.2.1.1 精密医療と遺伝子検査への注目の高まり
3.2.1.2 臍帯血バンクへの需要の高まり
3.2.1.3 バイオバンクの進化により、生物学的材料と関連情報の大量収集が急速に可能になる
3.2.2 市場抑制要因
3.2.2.1 民間スポンサーによる倫理的問題の提起
3.2.2.2 生物試料の収集に関する問題
3.2.2.3 バイオバンクの長期的持続可能性
3.2.3 市場機会
3.2.3.1 ヒト生物資源保管施設はバイオマーカー探索と個別化治療の進歩に不可欠である
3.2.3.2 循環器研究の機会
3.2.3.3 細胞治療のR＆Dへの注目の高まり
3.3 米国の関税：世界のバイオバンク市場への影響は？
3.3.1 概観
3.3.2 V字回復シナリオ
3.3.3 なぜV字回復なのか？
3.3.3.1 関税による影響
3.3.3.2 市場ダイナミクスと需要回復
3.3.3.3 政策と資金援助
3.3.3.4 回復のタイムフレーム
3.3.4 U字型回復シナリオ
3.3.4.1 なぜU字型回復なのか？
3.3.4.2 関税による影響
3.3.4.3 市場ダイナミクスと需要回復
3.3.4.4 政策と資金援助
3.3.4.5 回復のタイムフレーム
3.3.5 L字型回復シナリオ
3.3.5.1 なぜL字型回復なのか？
3.3.5.2 関税による影響
3.3.5.3 市場ダイナミクスと需要回復
3.3.5.4 政策と資金援助
3.3.5.5 回復のタイムフレーム
3.3.6 顧客が短期（2025-2030年）および長期（2025-2035年）計画に織り込むべき戦略的考慮事項とは？
3.3.7 米中貿易戦争がバイオバンク市場に与える影響
3.3.8 最も影響を受ける国は、これらの政策変更によってどのようなプラス効果とマイナス効果を経験するか？
3.4 ポーターのファイブフォース分析
3.4.1 サプライヤーの交渉力
3.4.2 買い手の交渉力
3.4.3 競争上のライバル関係
3.4.4 代替品の脅威
3.4.5 新規参入企業の脅威
3.5 PEST分析

4 バイオバンク市場分析：所有権別
4.1 主要な調査結果
4.2 所有セグメント市場魅力度指数
4.3 バイオバンキングの所有者別市場規模の推定と予測
4.4 国内／地域機関
4.4.1 2025〜2035年地域別市場予測（10億米ドル、AGR %)
4.4.2 地域別市場シェア、2025年～2035年(%)
4.5 大学
4.5.1 2025〜2035年地域別市場予測（10億米ドル、AGR %)
4.5.2 地域別市場シェア、2025年～2035年(%)
4.6 非営利
4.6.1 2025〜2035年地域別市場予測（10億米ドル、AGR %)
4.6.2 地域別市場シェア、2025年～2035年(%)
4.7 民間
4.7.1 2025〜2035年地域別市場予測（10億米ドル、AGR %)
4.7.2 地域別市場シェア、2025年～2035年(%)

5 バイオバンキング市場分析：サンプル別
5.1 主要な調査結果
5.2 サンプルセグメント市場魅力度指数
5.3 サンプル別バイオバンキング市場規模の推定と予測
5.4 血液製品
5.4.1 2025〜2035年の地域別市場予測（10億米ドル、AGR %)
5.4.2 地域別市場シェア、2025年～2035年(%)
5.5 ヒト組織
5.5.1 2025〜2035年地域別市場予測（10億米ドル、AGR %)
5.5.2 地域別市場シェア、2025年〜2035年(%)
5.6 核酸
5.6.1 2025〜2035年の地域別市場予測（10億米ドル、AGR %)
5.6.2 地域別市場シェア、2025年〜2035年(%)
5.7 細胞株
5.7.1 2025〜2035年の地域別市場展望（10億米ドル、AGR %)
5.7.2 地域別市場シェア、2025年～2035年(%)
5.8 生物学的製剤
5.8.1 2025〜2035年の地域別市場展望（10億米ドル、AGR %)
5.8.2 地域別市場シェア、2025年〜2035年(%)
5.9 その他
5.9.1 2025〜2035年の地域別市場展望（10億米ドル、AGR %)
5.9.2 地域別市場シェア、2025年〜2035年(%)

6 バイオバンキング市場分析：用途別
6.1 主要な調査結果
6.2 用途別セグメント市場魅力度指数
6.3 バイオバンキングの用途別市場規模の推定と予測
6.4 再生医療
6.4.1 2025〜2035年地域別市場予測（10億米ドル、AGR %)
6.4.2 地域別市場シェア、2025年〜2035年(%)
6.5 ライフサイエンス研究
6.5.1 2025〜2035年の地域別市場予測（10億米ドル、AGR %)
6.5.2 地域別市場シェア、2025年〜2035年(%)
6.6 臨床研究
6.6.1 2025〜2035年の地域別市場予測（10億米ドル、AGR %)
6.6.2 地域別市場シェア、2025年〜2035年(%)

7 バイオバンキング市場分析：製品・サービス別
7.1 主要な調査結果
7.2 製品・サービスセグメント市場魅力度指数
7.3 製品・サービス別バイオバンキング市場規模推定と予測
7.4 機器
7.4.1 2025〜2035年地域別市場予測（10億米ドル、AGR %)
7.4.2 地域別市場シェア、2025年〜2035年(%)
7.4.3 機器セグメントのタイプ別市場予測、2025-2035年（10億米ドル、AGR）
7.4.3.1 保管装置
7.4.3.2 サンプル分析装置
7.4.3.3 試料処理装置
7.4.3.4 試料輸送機器
7.5 消耗品
7.5.1 2025〜2035年地域別市場予測（億米ドル、AGR）
7.5.2 地域別市場シェア、2025年〜2035年(%)
7.5.3 消耗品セグメントのタイプ別市場予測、2025-2035年 (10億米ドル、AGR %)
7.5.3.1 保存用消耗品
7.5.3.2 分析用消耗品
7.5.3.3 加工用消耗品
7.5.3.4 コレクション消耗品
7.6 サービス
7.6.1 2025〜2035年地域別市場予測（10億米ドル、AGR）
7.6.2 地域別市場シェア、2025年〜2035年(%)
7.6.3 タイプ別サービスセグメント市場予測、2025-2035年（10億米ドル、AGR）
7.6.3.1 ストレージサービス
7.6.3.2 加工サービス
7.6.3.3 輸送サービス
7.6.3.4 供給サービス
7.7 ソフトウェア
7.7.1 2025〜2035年地域別市場予測（10億米ドル、AGR %)
7.7.2 地域別市場シェア、2025年〜2035年(%)

8 バイオバンキング市場分析：保管タイプ別
8.1 主要な調査結果
8.2 ストレージタイプセグメント市場魅力度指数
8.3 ストレージタイプ別バイオバンキング市場規模の推定と予測
8.4 自動化ストレージ
8.4.1 2025～2035年の地域別市場予測（10億米ドル、AGR）
8.4.2 地域別市場シェア、2025年～2035年(%)
8.5 手動ストレージ
8.5.1 2025～2035年の地域別市場展望（10億米ドル、AGR）
8.5.2 地域別市場シェア、2025年～2035年(%)

9 バイオバンキング市場分析：エンドユーザー別
9.1 主要な調査結果
9.2 エンドユーザーセグメント市場魅力度指数
9.3 エンドユーザー別バイオバンキング市場規模推計・予測
9.4 製薬企業・バイオテクノロジー企業
9.4.1 2025年～2035年の地域別市場予測（10億米ドル、AGR）
9.4.2 地域別市場シェア、2025年〜2035年(%)
9.5 CRO
9.5.1 2025年～2035年の地域別市場予測（10億米ドル、AGR）
9.5.2 地域別市場シェア、2025年～2035年(%)
9.6 学術・研究機関
9.6.1 2025年～2035年の地域別市場予測（10億米ドル、AGR）
9.6.2 地域別市場シェア、2025年〜2035年(%)
9.7 病院
9.7.1 2025年～2035年の地域別市場予測（10億米ドル、AGR）
9.7.2 地域別市場シェア、2025年～2035年(%)

10 バイオバンキング市場分析：地域別
10.1 主要な調査結果
10.2 地域別市場規模の推定と予測

11 北米のバイオバンキング市場分析
11.1 主要な調査結果
11.2 北米のバイオバンキング市場魅力度指数
11.3 北米のバイオバンキング市場：国別、2025年、2030年、2035年（10億米ドル）
11.4 北米のバイオバンキング国別市場規模推定と予測
11.5 北米のバイオバンキング市場規模推定と予測：所有権別
11.6 北米のバイオバンキング市場規模推定と予測：サンプル別
11.7 北米のバイオバンキング市場規模推定と予測：用途別
11.8 北米のバイオバンキング市場規模推定と予測：製品・サービス別
11.9 北米のバイオバンキング市場規模推定と予測：ストレージタイプ別
11.10 北米のバイオバンキング市場規模推定と予測：エンドユーザー別
11.11 アメリカのバイオバンキング市場分析
11.12 カナダのバイオバンキング市場分析

12 欧州のバイオバンキング市場分析
12.1 主要な調査結果
12.2 欧州のバイオバンキング市場魅力度指数
12.3 欧州のバイオバンキング市場：国別、2025年、2030年、2035年（10億米ドル）
12.4 欧州のバイオバンキング市場の国別推定と予測
12.5 欧州のバイオバンキング市場規模推定と予測：所有権別
12.6 欧州のバイオバンキング市場規模推定と予測：サンプル別
12.7 欧州のバイオバンキング市場規模推定と予測：用途別
12.8 欧州のバイオバンキング市場規模推定と予測：製品・サービス別
12.9 欧州のバイオバンキング市場規模推定と予測：保管タイプ別
12.10 欧州のバイオバンキング市場規模推定と予測：エンドユーザー別
12.11 ドイツのバイオバンキング市場分析
12.12 イギリスのバイオバンキング市場分析
12.13 フランスのバイオバンキング市場分析
12.14 イタリアのバイオバンキング市場分析
12.15 スペインのバイオバンク市場の分析
12.16 ロシアのバイオバンク市場の分析
12.17 その他のヨーロッパのバイオバンキング市場分析

13 アジア太平洋のバイオバンキング市場分析
13.1 主な調査結果
13.2 アジア太平洋のバイオバンキング市場魅力度指数
13.3 アジア太平洋のバイオバンキング国別市場、2025年、2030年、2035年（10億米ドル）
13.4 アジア太平洋のバイオバンキング市場規模の推定と予測：国別
13.5 アジア太平洋のバイオバンキング市場規模の推定と予測：所有権別
13.6 アジア太平洋のバイオバンキング市場規模の推定と予測：サンプル別
13.7 アジア太平洋のバイオバンキング市場規模の推定と予測：用途別
13.8 アジア太平洋のバイオバンキング市場規模の推定と予測：製品・サービス別
13.9 アジア太平洋地域バイオバンキング市場規模推定と予測：保存タイプ別
13.10 アジア太平洋地域バイオバンキング市場規模推定と予測：エンドユーザー別
13.11 日本バイオバンキング市場分析
13.12 中国バイオバンキング市場分析
13.13 インドバイオバンキング市場分析
13.14 オーストラリアバイオバンキング市場分析
13.15 韓国バイオバンキング市場分析
13.16 東南アジアバイオバンキング市場分析
13.17 アジア太平洋その他地域バイオバンキング市場分析

14 ラテンアメリカのバイオバンキング市場分析
14.1 主要な調査結果
14.2 ラテンアメリカのバイオバンキング市場魅力度指数
14.3 ラテンアメリカのバイオバンキング国別市場、2025年、2030年、2035年（10億米ドル）
14.4 ラテンアメリカのバイオバンキング国別市場規模推定と予測
14.5 ラテンアメリカのバイオバンキング市場規模推定と予測：所有権別
14.6 ラテンアメリカのバイオバンキング市場規模推定と予測：サンプル別
14.7 ラテンアメリカのバイオバンキング市場規模推定と予測：用途別
14.8 ラテンアメリカのバイオバンキング市場規模推定と予測：製品・サービス別
14.9 ラテンアメリカのバイオバンキング市場規模推定と予測：ストレージタイプ別
14.10 ラテンアメリカのバイオバンキング市場規模推定と予測：エンドユーザー別
14.11 ブラジルのバイオバンキング市場分析
14.12 メキシコのバイオバンキング市場分析
14.13 その他のラテンアメリカのバイオバンキング市場分析

15 MEAのバイオバンキング市場分析
15.1 主要な調査結果
15.2 MEAのバイオバンキング市場魅力度指数
15.3 MEAのバイオバンキングの国別市場規模、2025年、2030年、2035年（億米ドル）
15.4 MEAのバイオバンキング国別市場規模推定と予測
15.5 MEAのバイオバンキング市場規模推定と予測：所有権別
15.6 MEAのバイオバンキング市場規模推定と予測：サンプル別
15.7 MEAのバイオバンキング市場規模推定と予測：用途別
15.8 MEAのバイオバンキング市場規模推定と予測：製品・サービス別
15.9 MEAのバイオバンキング市場規模推定と予測：保管タイプ別
15.10 MEAのバイオバンキング市場規模推定と予測：エンドユーザー別
15.11 GCCのバイオバンキング市場分析
15.12 南アフリカのバイオバンキング市場分析
15.13 その他のMEAバイオバンキング市場分析

16 会社概要
16.1 サーモフィッシャーサイエンティフィック
16.1.1 会社概要
16.1.2 会社概要
16.1.3 財務分析
16.1.3.1 純収入、2020-2024年
16.1.3.2 地域市場シェア、2024年
16.1.3.3 R＆D、2020-2024年
16.1.4 製品ベンチマーク
16.2 PHCホールディングス
16.2.1 会社概要
16.2.2 会社概要
16.2.3 製品ベンチマーク
16.2.4 戦略的展望
16.3 ハミルトン社
16.3.1 会社概要
16.3.2 会社概要
16.3.3 製品ベンチマーク
16.4 アバンター社
16.4.1 会社概要
16.4.2 会社概要
16.4.3 財務分析
16.4.3.1 純収入、2020-2024年
16.4.3.2 地域市場シェア、2024年
16.4.4 製品ベンチマーク
16.5 QIAGEN
16.5.1 会社概要
16.5.2 会社概要
16.5.3 財務分析
16.5.3.1 純収入、2020-2024年
16.5.3.2 地域市場シェア、2024年
16.5.3.3 R＆D、2020-2024年
16.5.4 製品ベンチマーク
16.6 テカントレーディング
16.6.1 会社概要
16.6.2 会社概要
16.6.3 製品ベンチマーク
16.7 メルク KGaA
16.7.1 会社概要
16.7.2 会社概要
16.7.3 財務分析
16.7.3.1 純収入、2020-2024年
16.7.3.2 地域市場シェア、2024年
16.7.3.3 R＆D、2020-2024年
16.7.4 製品ベンチマーク
16.8 クライオポート社
16.8.1 会社概要
16.8.2 会社概要
16.8.3 財務分析
16.8.3.1 純収入、2020-2024年
16.8.3.2 地域市場シェア、2024年
16.8.3.3 R＆D、2020-2024年
16.8.4 製品ベンチマーク
16.8.5 戦略的展望
16.9 アゼンタ・インク
16.9.1 会社概要
16.9.2 会社概要
16.9.3 財務分析
16.9.3.1 純収入、2020-2024年
16.9.3.2 R＆D、2020-2024年
16.9.4 製品ベンチマーク
16.10 アイセネット
16.10.1 会社概要
16.10.2 会社概要
16.10.3 製品ベンチマーク
16.11 CTIバイオテック
16.11.1 会社概要
16.11.2 会社概要
16.11.3 製品ベンチマーク
16.12 ボカバイオリスティックス
16.12.1 会社概要
16.12.2 会社概要
16.12.3 製品ベンチマーク
16.12.4 戦略的展望
16.13 バイオIVT
16.13.1 会社概要
16.13.2 会社概要
16.13.3 製品ベンチマーク
16.13.4 戦略的展望
16.14 USバイオラボ・コーポレーション
16.14.1 会社概要
16.14.2 会社概要
16.14.3 製品ベンチマーク
16.15 プロテオジェネックス
16.15.1 会社概要
16.15.2 会社概要
16.15.3 製品ベンチマーク
16.16 アスキオン社
16.16.1 会社概要
16.16.2 会社概要
16.16.3 製品ベンチマーク
16.17 ステムセル・テクノロジーズ
16.17.1 会社概要
16.17.2 会社概要
16.17.3 製品ベンチマーク
16.17.4 戦略的展望
16.18 サイセーフ
16.18.1 会社概要
16.18.2 会社概要
16.18.3 製品ベンチマーク
16.19 チャールズ・リバー・ラボラトリーズ・インターナショナル
16.19.1 会社概要
16.19.2 会社概要
16.19.3 財務分析
16.19.3.1 純収入、2020-2024年
16.19.3.2 地域市場シェア（2024年
16.19.4 製品ベンチマーク
16.19.5 戦略的展望
16.20 BD
16.20.1 会社概要
16.20.2 会社概要
16.20.3 財務分析
16.20.3.1 純売上高、2020-2024年
16.20.3.2 地域市場シェア、2024年
16.20.3.3 R＆D、2020-2024年
16.20.4 製品ベンチマーク
16.21 ラブコープ
16.21.1 会社概要
16.21.2 会社概要
16.21.3 財務分析
16.21.3.1 純収入、2020-2024年
16.21.3.2 地域市場シェア（2024年
16.21.4 製品ベンチマーク

17 結論と提言
17.1 ビジョンゲインからの結びの言葉
17.2 市場プレイヤーへの提言

 

ページTOPに戻る



図表リスト

List of Tables
Table 1 Biobanking Market Snapshot, 2025 & 2035 (US$ Billion, CAGR %)
Table 2 Biobanking Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 3 Biobanking Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%): U Shaped Recovery
Table 4 Biobanking Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%): L Shaped Recovery
Table 5 Biobanking Market Forecast by Ownership, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 6 National/ Regional Agencies Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 7 Universities Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 8 Non-profit Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 9 Private Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 10 Biobanking Market Forecast by Sample, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 11 Blood Products Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 12 Human Tissues Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 13 Nucleic Acid Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 14 Cell Lines Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 15 Biological Fluids Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 16 Others Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 17 Biobanking Market Forecast by Application, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 18 Regenerative Medicine Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 19 Life Science Research Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 20 Clinical Research Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 21 Biobanking Market Forecast by Products and Services, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 22 Equipment Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 23 Biobanking Market Forecast by Products and Services, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 24 Consumables Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 25 Biobanking Market Forecast by Products and Services, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 26 Services Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 27 Biobanking Market Forecast by Products and Services, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 28 Software Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 29 Biobanking Market Forecast by Application, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 30 Automated Storage Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 31 Manual Storage Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 32 Biobanking Market Forecast by End-users, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 33 Pharmaceutical & Biotechnology Companies Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 34 CROs Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 35 Academic & Research Institutes Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 36 Hospitals Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 37 Biobanking Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 38 North America Biobanking Market Forecast by Country, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 39 North America Biobanking Market Forecast by Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 40 North America Biobanking Market Forecast by Sample, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 41 North America Biobanking Market Forecast by Application, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 42 North America Biobanking Market Forecast by Products and Services, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 43 North America Biobanking Market Forecast by Country, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 44 North America Biobanking Market Forecast by End-users, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 45 U.S. Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 46 Canada Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 47 Europe Biobanking Market Forecast by Country, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 48 Europe Biobanking Market Forecast by Ownership, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 49 Europe Biobanking Market Forecast by Sample, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 50 Europe Biobanking Market Forecast by Application, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 51 Europe Biobanking Market Forecast by Products and Services, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 52 Europe Biobanking Market Forecast by Country, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 53 Europe Biobanking Market Forecast by End-users, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 54 Germany Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 55 UK Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 56 France Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 57 Italy Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 58 Spain Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 59 Russia Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 60 Rest of Europe Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 61 Asia Pacific Biobanking Market Forecast by Country, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 62 Asia Pacific Biobanking Market Forecast by Ownership, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 63 Asia Pacific Biobanking Market Forecast by Sample, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 64 Asia Pacific Biobanking Market Forecast by Application, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 65 Asia Pacific Biobanking Market Forecast by Products and Services, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 66 Asia Pacific Biobanking Market Forecast by Country, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 67 Asia Pacific Biobanking Market Forecast by End-users, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 68 Japan Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 69 China Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 70 India Biobanking Institutes
Table 71 India Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 72 Australia Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 73 South Korea Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 74 South-East Asia Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 75 Rest of Asia Pacific Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 76 Latin America Biobanking Market Forecast by Country, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 77 Latin America Biobanking Market Forecast by Ownership, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 78 Latin America Biobanking Market Forecast by Sample, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 79 Latin America Biobanking Market Forecast by Application, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 80 Latin America Biobanking Market Forecast by Products and Services, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 81 Latin America Biobanking Market Forecast by Country, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 82 Latin America Biobanking Market Forecast by End-users, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 83 Brazil Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 84 Mexico Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 85 Rest of Latin America Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 86 MEA Biobanking Market Forecast by Country, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 87 MEA Biobanking Market Forecast by Ownership, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 88 MEA Biobanking Market Forecast by Sample, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 89 MEA Biobanking Market Forecast by Application, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 90 MEA Biobanking Market Forecast by Products and Services, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 91 MEA Biobanking Market Forecast by Country, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 92 MEA Biobanking Market Forecast by End-users, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 93 GCC Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 94 South Africa Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 95 Rest of MEA Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 96 Thermo Fisher Scientific Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 97 Thermo Fisher Scientific Inc.: Product Benchmarking
Table 98 PHC Holdings Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 99 PHC Holdings Corporation: Product Benchmarking
Table 100 PHC Holdings Corporation: Strategic Outlook
Table 101 Hamilton Company: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 102 Hamilton Company: Product Benchmarking
Table 103 Avantor Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 104 Avantor Inc.: Product Benchmarking
Table 105 QIAGEN: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 106 QIAGEN: Product Benchmarking
Table 107 Tecan Trading AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 108 Tecan Trading AG: Product Benchmarking
Table 109 Merck KGaA: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 110 Merck KGaA: Product Benchmarking
Table 111 Cryoport, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 112 Cryoport, Inc.: Product Benchmarking
Table 113 Cryoport, Inc.: Strategic Outlook
Table 114 Azenta Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 115 Azenta Inc.: Product Benchmarking
Table 116 ISENET: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 117 ISENET: Product Benchmarking
Table 118 CTIBiotech: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 119 CTIBiotech: Product Benchmarking
Table 120 Boca Biolistics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 121 Boca Biolistics: Product Benchmarking
Table 122 Boca Biolistics: Strategic Outlook
Table 123 BIOIVT: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 124 BIOIVT: Product Benchmarking
Table 125 BIOIVT: Strategic Outlook
Table 126 US Biolab Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 127 US Biolab Corporation: Product Benchmarking
Table 128 ProteoGenex Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 129 ProteoGenex Inc.: Product Benchmarking
Table 130 ASKION GmbH: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 131 ASKION GmbH: Product Benchmarking
Table 132 STEMCELL Technologies: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 133 STEMCELL Technologies: Product Benchmarking
Table 134 STEMCELL Technologies: Strategic Outlook
Table 135 SciSafe: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 136 SciSafe: Product Benchmarking
Table 137 Charles River Laboratories International, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 138 Charles River Laboratories International, Inc.: Product Benchmarking
Table 139 Charles River Laboratories International, Inc.: Strategic Outlook
Table 140 BD: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 141 BD: Product Benchmarking
Table 142 Labcorp: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 143 Labcorp: Product Benchmarking
 
List of Figures
Figure 1 Biobanking Market Segmentation
Figure 2 Biobanking Market by Ownership: Market Attractiveness Index
Figure 3 Biobanking Market by Sample: Market Attractiveness Index
Figure 4 Biobanking Market by Application: Market Attractiveness Index
Figure 5 Biobanking Market by Products and Services: Market Attractiveness Index
Figure 6 Biobanking Market by End-users: Market Attractiveness Index
Figure 7 Biobanking Market Attractiveness Index by Region
Figure 8 Biobanking Market: Market Dynamics
Figure 1 Biobanking Market by Region, 2025-2035 (US$ Billion, AGR %), Tariff Impact: V-Shaped Recovery Scenario
Figure 2 Biobanking Market by Region, 2025-2035 (US$ Billion, AGR %), Tariff Impact: U-Shaped Recovery Scenario
Figure 3 Biobanking Market by Region, 2025-2035 (US$ Billion, AGR %), Tariff Impact: L-Shaped Recovery Scenario
Figure 4 Short Term & Long Term Planning
Figure 5 Impact of U.S. and China Trade War
Figure 6 Most Impacted Countries
Figure 7 Biobanking Market: Porter’s Five Forces Analysis
Figure 8 Biobanking Market: PEST Analysis
Figure 9 Biobanking Market Attractiveness Index by Ownership
Figure 10 Biobanking Market Forecast by Ownership, 2025-2035 (US$ Billion, AGR %)
Figure 11 Biobanking Market Share Forecast by Ownership, 2025, 2030, 2035 (%)
Figure 12 National/Regional Agencies Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 13 National/Regional Agencies Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 14 Universities Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 15 Universities Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 16 Non-profit Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 17 Non-profit Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 18 Private Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 19 Private Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 20 Biobanking Market Attractiveness Index by Ownership
Figure 21 Biobanking Market Forecast by Sample, 2025-2035 (US$ Billion, AGR %)
Figure 22 Biobanking Market Share Forecast by Sample, 2025, 2030, 2035 (%)
Figure 23 Blood Products Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 24 Blood Products Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 25 Human Tissues Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 26 Human Tissues Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 27 Nucleic Acids Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 28 Nucleic Acids Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 29 Cell Lines Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 30 Cell Lines Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 31 Biological Fluids Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 32 Biological Fluids Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 33 Others Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 34 Others Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 35 Biobanking Market Attractiveness Index by Application
Figure 36 Biobanking Market Forecast by Application, 2025-2035 (US$ Billion, AGR %)
Figure 37 Biobanking Market Share Forecast by Application, 2025, 2030, 2035 (%)
Figure 38 Regenerative Medicine Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 39 Regenerative Medicine Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 40 Life Science Research Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 41 Life Science Research Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 42 Clinical Research Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 43 Clinical Research Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 44 Biobanking Market Attractiveness Index by Products and Services
Figure 45 Biobanking Market Forecast by Products and Services, 2025-2035 (US$ Billion, AGR %)
Figure 46 Biobanking Market Share Forecast by Products and Services, 2025, 2030, 2035 (%)
Figure 47 Equipment Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 48 Equipment Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 49 Equipment Segment Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
Figure 50 Consumables Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 51 Consumables Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 52 Consumables Segment Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
Figure 53 Services Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 54 Services Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 55 Services Segment Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
Figure 56 Software Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 57 Software Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 58 Biobanking Market Attractiveness Index by Storage Type
Figure 59 Biobanking Market Forecast by Storage Type, 2025-2035 (US$ Billion, AGR %)
Figure 60 Biobanking Market Share Forecast by Storage Type, 2025, 2030, 2035 (%)
Figure 61 Automated Storage Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 62 Automated Storage Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 63 Manual Storage Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 64 Manual Storage Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 65 Biobanking Market Attractiveness Index by End-users
Figure 66 Biobanking Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %)
Figure 67 Biobanking Market Share Forecast by End-users, 2025, 2030, 2035 (%)
Figure 68 Pharmaceutical & Biotechnology Companies Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 69 Pharmaceutical & Biotechnology Companies Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 70 CROs Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 71 CROs Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 72 Academic & Research Institutes Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 73 Academic & Research Institutes Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 74 Hospitals Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 75 Hospitals Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 76 Biobanking Market Forecast by Region 2025, 2030, 2035 (Revenue, CAGR%)
Figure 77 Biobanking Market Share Forecast by Region 2025, 2030, 2035 (%)
Figure 78 Biobanking Market by Region, 2025-2035 (US$ Billion, AGR %)
Figure 79 North America Biobanking Market Attractiveness Index
Figure 80 North America Biobanking Market by Region, 2025, 2030 & 2035 (US$ Billion)
Figure 81 North America Biobanking Market Forecast by Country, 2025-2035 (US$ Billion)
Figure 82 North America Biobanking Market Share Forecast by Country, 2025 & 2035 (%)
Figure 83 North America Biobanking Market Forecast by Ownership, 2025-2035 (US$ Billion, AGR %)
Figure 84 North America Biobanking Market Share Forecast by Ownership, 2025 & 2035 (%)
Figure 85 North America Biobanking Market Forecast by Sample, 2025-2035 (US$ Billion, AGR %)
Figure 86 North America Biobanking Market Share Forecast by Sample, 2025 & 2035 (%)
Figure 87 North America Biobanking Market Forecast by Application, 2025-2035 (US$ Billion, AGR %)
Figure 88 North America Biobanking Market Share Forecast by Application, 2025 & 2035 (%)
Figure 89 North America Biobanking Market Forecast by Products and Services, 2025-2035 (US$ Billion, AGR %)
Figure 90 North America Biobanking Market Share Forecast by Products and Services, 2025 & 2035 (%)
Figure 91 North America Biobanking Market Forecast by Storage Type, 2025-2035 (US$ Billion, AGR %)
Figure 92 North America Biobanking Market Share Forecast by Storage Type, 2025 & 2035 (%)
Figure 93 North America Biobanking Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %)
Figure 94 North America Biobanking Market Share Forecast by End-users, 2025 & 2035 (%)
Figure 95 U.S. Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 96 Canada Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 97 Europe Biobanking Market Attractiveness Index
Figure 98 Europe Biobanking Market by Region, 2025, 2030 & 2035 (US$ Billion)
Figure 99 Europe Biobanking Market Forecast by Country, 2025-2035 (US$ Billion)
Figure 100 Europe Biobanking Market Share Forecast by Country, 2025 & 2035 (%)
Figure 101 Europe Biobanking Market Forecast by Ownership, 2025-2035 (US$ Billion, AGR %)
Figure 102 Europe Biobanking Market Share Forecast by Ownership, 2025 & 2035 (%)
Figure 103 Europe Biobanking Market Forecast by Sample, 2025-2035 (US$ Billion, AGR %)
Figure 104 Europe Biobanking Market Share Forecast by Sample, 2025 & 2035 (%)
Figure 105 Europe Biobanking Market Forecast by Application, 2025-2035 (US$ Billion, AGR %)
Figure 106 Europe Biobanking Market Share Forecast by Application, 2025 & 2035 (%)
Figure 107 Europe Biobanking Market Forecast by Products and Services, 2025-2035 (US$ Billion, AGR %)
Figure 108 Europe Biobanking Market Share Forecast by Products and Services, 2025 & 2035 (%)
Figure 109 Europe Biobanking Market Forecast by Storage Type, 2025-2035 (US$ Billion, AGR %)
Figure 110 Europe Biobanking Market Share Forecast by Storage Type, 2025 & 2035 (%)
Figure 111 Europe Biobanking Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %)
Figure 112 Europe Biobanking Market Share Forecast by End-users, 2025 & 2035 (%)
Figure 113 Germany Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 114 UK Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 115 France Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 116 Italy Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 117 Spain Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 118 Russia Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 119 Rest of Europe Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 120 Asia Pacific Biobanking Market Attractiveness Index
Figure 121 Asia Pacific Biobanking Market by Region, 2025, 2030 & 2035 (US$ Billion)
Figure 122 Asia Pacific Biobanking Market Forecast by Country, 2025-2035 (US$ Billion)
Figure 123 Asia Pacific Biobanking Market Share Forecast by Country, 2025 & 2035 (%)
Figure 124 Asia Pacific Biobanking Market Forecast by Ownership, 2025-2035 (US$ Billion, AGR %)
Figure 125 Asia Pacific Biobanking Market Share Forecast by Ownership, 2025 & 2035 (%)
Figure 126 Asia Pacific Biobanking Market Forecast by Sample, 2025-2035 (US$ Billion, AGR %)
Figure 127 Asia Pacific Biobanking Market Share Forecast by Sample, 2025 & 2035 (%)
Figure 128 Asia Pacific Biobanking Market Forecast by Application, 2025-2035 (US$ Billion, AGR %)
Figure 129 Asia Pacific Biobanking Market Share Forecast by Application, 2025 & 2035 (%)
Figure 130 Asia Pacific Biobanking Market Forecast by Products and Services, 2025-2035 (US$ Billion, AGR %)
Figure 131 Asia Pacific Biobanking Market Share Forecast by Products and Services, 2025 & 2035 (%)
Figure 132 Asia Pacific Biobanking Market Forecast by Storage Type, 2025-2035 (US$ Billion, AGR %)
Figure 133 Asia Pacific Biobanking Market Share Forecast by Storage Type, 2025 & 2035 (%)
Figure 134 Asia Pacific Biobanking Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %)
Figure 135 Asia Pacific Biobanking Market Share Forecast by End-users, 2025 & 2035 (%)
Figure 136 Japan Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 137 China Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 138 India Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 139 Australia Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 140 South Korea Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 141 South-East Asia Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 142 Rest of Asia Pacific Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 143 Latin America Biobanking Market Attractiveness Index
Figure 144 Latin America Biobanking Market by Region, 2025, 2030 & 2035 (US$ Billion)
Figure 145 Latin America Biobanking Market Forecast by Country, 2025-2035 (US$ Billion)
Figure 146 Latin America Biobanking Market Share Forecast by Country, 2025 & 2035 (%)
Figure 147 Latin America Biobanking Market Forecast by Ownership, 2025-2035 (US$ Billion, AGR %)
Figure 148 Latin America Biobanking Market Share Forecast by Ownership, 2025 & 2035 (%)
Figure 149 Latin America Biobanking Market Forecast by Sample, 2025-2035 (US$ Billion, AGR %)
Figure 150 Latin America Biobanking Market Share Forecast by Sample, 2025 & 2035 (%)
Figure 151 Latin America Biobanking Market Forecast by Application, 2025-2035 (US$ Billion, AGR %)
Figure 152 Latin America Biobanking Market Share Forecast by Application, 2025 & 2035 (%)
Figure 153 Latin America Biobanking Market Forecast by Products and Services, 2025-2035 (US$ Billion, AGR %)
Figure 154 Latin America Biobanking Market Share Forecast by Products and Services, 2025 & 2035 (%)
Figure 155 Latin America Biobanking Market Forecast by Storage Type, 2025-2035 (US$ Billion, AGR %)
Figure 156 Latin America Biobanking Market Share Forecast by Storage Type, 2025 & 2035 (%)
Figure 157 Latin America Biobanking Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %)
Figure 158 Latin America Biobanking Market Share Forecast by End-users, 2025 & 2035 (%)
Figure 159 Brazil Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 160 Mexico Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 161 Rest of Latin America Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 162 MEA Biobanking Market Attractiveness Index
Figure 163 MEA Biobanking Market by Region, 2025, 2030 & 2035 (US$ Billion)
Figure 164 MEA Biobanking Market Forecast by Country, 2025-2035 (US$ Billion)
Figure 165 MEA Biobanking Market Share Forecast by Country, 2025 & 2035 (%)
Figure 166 MEA Biobanking Market Forecast by Ownership, 2025-2035 (US$ Billion, AGR %)
Figure 167 MEA Biobanking Market Share Forecast by Ownership, 2025 & 2035 (%)
Figure 168 MEA Biobanking Market Forecast by Sample, 2025-2035 (US$ Billion, AGR %)
Figure 169 MEA Biobanking Market Share Forecast by Sample, 2025 & 2035 (%)
Figure 170 MEA Biobanking Market Forecast by Application, 2025-2035 (US$ Billion, AGR %)
Figure 171 MEA Biobanking Market Share Forecast by Application, 2025 & 2035 (%)
Figure 172 MEA Biobanking Market Forecast by Products and Services, 2025-2035 (US$ Billion, AGR %)
Figure 173 MEA Biobanking Market Share Forecast by Products and Services, 2025 & 2035 (%)
Figure 174 MEA Biobanking Market Forecast by Storage Type, 2025-2035 (US$ Billion, AGR %)
Figure 175 MEA Biobanking Market Share Forecast by Storage Type, 2025 & 2035 (%)
Figure 176 MEA Biobanking Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %)
Figure 177 MEA Biobanking Market Share Forecast by End-users, 2025 & 2035 (%)
Figure 178 GCC Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 179 South Africa Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 180 Rest of MEA Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 181 Thermo Fisher Scientific Inc.: Net Revenue, 2020-2024 (US$ Million, AGR%)
Figure 182 Thermo Fisher Scientific Inc.: Regional Market Shares (%), 2024
Figure 183 Thermo Fisher Scientific Inc.: R&D, 2020-2024 (US$ Million, AGR%)
Figure 184 Avantor Inc.: Net Revenue, 2020-2024 (US$ Million, AGR%)
Figure 185 Avantor Inc.: Regional Market Shares (%), 2024
Figure 186 QIAGEN: Net Revenue, 2020-2024 (US$ Million, AGR%)
Figure 187 QIAGEN: Regional Market Shares (%), 2024
Figure 188 QIAGEN: R&D, 2020-2024 (US$ Million, AGR%)
Figure 189 Merck KGaA: Net Revenue, 2020-2024 (US$ Million, AGR%)
Figure 190 Merck KGaA: Regional Market Shares (%), 2024
Figure 191 Merck KGaA: R&D, 2020-2024 (US$ Million, AGR%)
Figure 192 Cryoport, Inc.: Net Revenue, 2020-2024 (US$ Million, AGR%)
Figure 193 Cryoport, Inc.: Regional Market Shares (%), 2024
Figure 194 Cryoport, Inc.: R&D, 2020-2024 (US$ Million, AGR%)
Figure 195 Azenta Inc.: Net Revenue, 2020-2024 (US$ Million, AGR%)
Figure 196 Azenta Inc.: R&D, 2020-2024 (US$ Million, AGR%)
Figure 197 Charles River Laboratories International, Inc.: Net Revenue, 2020-2024 (US$ Million, AGR%)
Figure 198 Charles River Laboratories International, Inc.: Regional Market Shares (%), 2024
Figure 199 BD: Net Revenue, 2020-2024 (US$ Million, AGR%)
Figure 200 BD: Regional Market Shares (%), 2024
Figure 201 BD: R&D, 2020-2024 (US$ Million, AGR%)
Figure 202 Labcorp: Net Revenue, 2020-2024 (US$ Million, AGR%)
Figure 203 Labcorp: Regional Market Shares (%), 2024

　

ページTOPに戻る


　

Summary

Description

 

The Biobanking Market Report 2025-2035 (Including Impact of U.S. Trade Tariffs): This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Accelerated Market Growth Driven by Multi-Omics and AI Integration

The global biobanking market—valued at US$83.1 billion in 2025 and projected to reach US$194.0 billion by 2035 is accelerating as the sector transitions from conventional sample storage to large-scale, data-rich, multi-omics and AI-enabled research infrastructure. Historically centred on limited academic repositories, biobanks have evolved into globally interconnected platforms managing millions of high-quality samples linked to clinical, genomic, and proteomic datasets. This transformation reflects a broader industry shift toward the active utilisation of biospecimens in sequencing, biomarker discovery, drug development, and translational medicine.

Large national and institutional initiatives—such as advanced proteomic mapping involving hundreds of thousands of samples demonstrate the sector’s expanding role. Notably, on 13 January 2025, Illumina announced a pilot proteomics programme analysing 50,000 UK Biobank samples alongside deCODE Genetics, Standard BioTools, Tecan, GSK, Johnson & Johnson, and Novartis, leveraging its next-generation Illumina Protein Prep™ platform. Such collaborations highlight how modern biobanks are becoming critical engines for precision medicine, disease-risk analysis, and long-term population health research, driving robust market expansion.

What would be the Impact of US Trade Tariffs on the Global Biobanking Market?

U.S. trade tariffs are exerting upward pressure on cost structures across the biobanking value chain, particularly for imported ultra-low-temperature freezers, cryogenic systems, automation modules, consumables, and LIMS-related hardware. These cost increases are prompting biobanks to reassess procurement and shift toward regional or tariff-exempt suppliers to maintain budget stability. The tariffs are also slowing infrastructure upgrades, delaying expansion timelines, and constraining capital allocation for advanced automation and digitalisation projects. In response, global suppliers are restructuring manufacturing footprints, while service providers adjust pricing for storage and processing to offset rising costs. Overall, the tariff environment is accelerating trends toward localisation, multi-vendor sourcing, and financially disciplined operational planning across the biobanking sector.

What Questions Should You Ask before Buying a Market Research Report?

  • How is the Biobanking market evolving?
  • What is driving and restraining the Biobanking market?
  • How will each Biobanking submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2035?
  • How will the market shares for each Biobanking submarket develop from 2025 to 2035?
  • What will be the main driver for the overall market from 2025 to 2035?
  • Will leading Biobanking markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
  • How will the market shares of the national markets change by 2035 and which geographical region will lead the market in 2035?
  • Who are the leading players and what are their prospects over the forecast period?
  • What are the Biobanking projects for these leading companies?
  • How will the industry evolve during the period between 2025 and 2035? What are the implications of
  • Biobanking projects taking place now and over the next 10 years?
  • Is there a greater need for product commercialisation to further scale the Biobanking market?
  • Where is the Biobanking market heading and how can you ensure you are at the forefront of the market?
  • What are the best investment options for new product and service lines?
  • What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the Biobanking market today, and over the next 10 years:

  • Our 355-page report provides 121 tables and 182 charts/graphs exclusively to you.
  • The report highlights key lucrative areas in the industry so you can target them – NOW.
  • It contains in-depth analysis of global, regional and national sales and growth.
  • It highlights for you the key successful trends, changes and revenue projections made by your competitors.

Forecasts to 2035 and other analyses reveal commercial prospects

  • In addition to revenue forecasting to 2035, our new study provides you with recent results, growth rates, and market shares.
  • You will find original analyses, with business outlooks and developments.
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, and restraints), Porter’s Five Forces Analysis, PEST Analysis and recent developments.

Segments Covered in the Report

Products and Services

  • Equipment
    – Storage Equipment
    – Sample Analysis Equipment
    – Sample Processing Equipment
    – Sample Transport Equipment
  • Consumables
    – Storage Consumables
    – Analysis Consumables
    – Processing Consumables
    – Collection Consumables
  • Services
    – Storage Services
    – Processing Services
    – Transport Services
    – Supply Services
    Software

Storage Type

  • Automated Storage
  • Manual Storage

Ownership

  • National/Regional Agencies
  • Universities
  • Non-profit
  • Private

Sample

  • Blood Products
  • Human Tissues
  • Nucleic Acids
  • Cell Lines
  • Biological Fluids

Application

  • Regenerative Medicine
  • Life Science Research
  • Clinical Research

End-users

  • Pharmaceutical & Biotechnology Companies
  • CROs
  • Academic & Research Institutes
  • Hospitals

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 26 leading national markets:

North America

  • U.S.
  • Canada

Europe

  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Switzerland
  • Rest of Europe

Asia Pacific

  • Japan
  • China
  • India
  • Australia
  • South Korea
  • South-East Asia
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of Latin America

MEA

  • GCC
  • South Africa
  • Rest of MEA

Biobanking Market Report 2025-2035

The report also includes profiles and for some of the leading companies in the Biobanking Market, 2025 to 2035, with a focus on this segment of these companies’ operations.

Leading companies and the potential for market growth

  • ASKION GmbH
  • Avantor, Inc.
  • Azenta Inc.
  • BD
  • BioIVT
  • Boca Biolistics
  • Charles River Laboratories International, Inc.
  • Cryoport, Inc.
  • CTIBiotech
  • Hamilton Company
  • ISENET
  • Labcorp
  • Merck KGaA
  • PHC Holdings Corporation
  • ProteoGenex Inc.
  • QIAGEN
  • SciSafe
  • STEMCELL Technologies
  • Tecan Trading AG
  • Thermo Fisher Scientific Inc.
  • US Biolab Corporation

Overall world revenue for Biobanking Market, 2025 to 2035 in terms of value the market will surpass US$80.0 billion in 2025, our work calculates. We predict strong revenue growth through to 2035. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Biobanking Market, 2025 to 2035 report help you?

In summary, our 350+ page report provides you with the following knowledge:

  • Revenue forecasts to 2035 for Biobanking Market 2025 to 2035, with forecasts for type and phase, each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.
  • Revenue forecasts to 2035 for five regional and 26 key national markets – See forecasts for the Biobanking Market, 2025 to 2035 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
  • Prospects for established firms and those seeking to enter the market – including company profiles for 22 of the major companies involved in the Biobanking Market, 2025 to 2035.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

 

 



ページTOPに戻る


Table of Contents

1 Report Overview
1.1 Objectives of the Study
1.2 Introduction to Biobanking Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report Include:
1.6 Who is This Report For?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain

2 Executive Summary

3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.2.1 Market Driving Factors
3.2.1.1 Increased Focus on Precision Medicine and Genetic Testing
3.2.1.2 Growing Demand for Umbilical Cord Blood Banking
3.2.1.3 Evolution of Biobanks Rapidly Enabling Massive Collections of Biological Materials and Associated Information
3.2.2 Market Restraining Factors
3.2.2.1 Private Sponsorship Has Raised a Number of Ethical Issues
3.2.2.2 Issues Related to Biospecimen Sample Procurement
3.2.2.3 Long-term Sustainability of Biobanks
3.2.3 Market Opportunities
3.2.3.1 Human Biospecimens are Essential for Progress in Biomarker Discovery and Customised Treatment
3.2.3.2 Opportunities for Cardiovascular Research
3.2.3.3 Growing Focus on the R&D of Cell Therapies
3.3 U.S. Tariffs: What’s the Impact on Global Biobanking Market?
3.3.1 Overview
3.3.2 V-Shaped Recovery Scenario
3.3.3 Why V-Shaped Recovery?
3.3.3.1 Impact from Tariffs
3.3.3.2 Market Dynamics and Demand Recovery
3.3.3.3 Policy and Funding Support
3.3.3.4 Timeframe for Recovery
3.3.4 U-Shaped Recovery Scenario
3.3.4.1 Why U-Shaped Recovery?
3.3.4.2 Impact from Tariffs
3.3.4.3 Market Dynamics and Demand Recovery
3.3.4.4 Policy and Funding Support
3.3.4.5 Timeframe for Recovery
3.3.5 L Shaped Recovery Scenario
3.3.5.1 Why L-Shaped Recovery?
3.3.5.2 Impact from Tariffs
3.3.5.3 Market Dynamics and Demand Recovery
3.3.5.4 Policy and Funding Support
3.3.5.5 Timeframe for Recovery
3.3.6 What Strategic Considerations Should Clients Factor into Their Near-term (2025–2030) and Long-term (2025–2035) Planning?
3.3.7 Impact of U.S. and China Trade War on Biobanking Market
3.3.8 How Might the Most Impacted Countries Experience Positive and Negative Effects Resulting from These Policy Changes?
3.4 Porter’s Five Forces Analysis
3.4.1 Bargaining Power of Suppliers
3.4.2 Bargaining Power of Buyers
3.4.3 Competitive Rivalry
3.4.4 Threat of Substitutes
3.4.5 Threat of New Entrants
3.5 PEST Analysis

4 Biobanking Market Analysis by Ownership
4.1 Key Findings
4.2 Ownership Segment: Market Attractiveness Index
4.3 Biobanking Market Size Estimation and Forecast by Ownership
4.4 National/Regional Agencies
4.4.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
4.4.2 Market Share by Region, 2025 & 2035 (%)
4.5 Universities
4.5.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
4.5.2 Market Share by Region, 2025 & 2035 (%)
4.6 Non-profit
4.6.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
4.6.2 Market Share by Region, 2025 & 2035 (%)
4.7 Private
4.7.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
4.7.2 Market Share by Region, 2025 & 2035 (%)

5 Biobanking Market Analysis by Sample
5.1 Key Findings
5.2 Sample Segment: Market Attractiveness Index
5.3 Biobanking Market Size Estimation and Forecast by Sample
5.4 Blood Products
5.4.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
5.4.2 Market Share by Region, 2025 & 2035 (%)
5.5 Human Tissues
5.5.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
5.5.2 Market Share by Region, 2025 & 2035 (%)
5.6 Nucleic Acids
5.6.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
5.6.2 Market Share by Region, 2025 & 2035 (%)
5.7 Cell Lines
5.7.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
5.7.2 Market Share by Region, 2025 & 2035 (%)
5.8 Biological Fluids
5.8.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
5.8.2 Market Share by Region, 2025 & 2035 (%)
5.9 Others
5.9.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
5.9.2 Market Share by Region, 2025 & 2035 (%)

6 Biobanking Market Analysis by Application
6.1 Key Findings
6.2 Application Segment: Market Attractiveness Index
6.3 Biobanking Market Size Estimation and Forecast by Application
6.4 Regenerative Medicine
6.4.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
6.4.2 Market Share by Region, 2025 & 2035 (%)
6.5 Life Science Research
6.5.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
6.5.2 Market Share by Region, 2025 & 2035 (%)
6.6 Clinical Research
6.6.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
6.6.2 Market Share by Region, 2025 & 2035 (%)

7 Biobanking Market Analysis by Products and Services
7.1 Key Findings
7.2 Products and Services Segment: Market Attractiveness Index
7.3 Biobanking Market Size Estimation and Forecast by Products and Services
7.4 Equipment
7.4.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
7.4.2 Market Share by Region, 2025 & 2035 (%)
7.4.3 Equipment Segment Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
7.4.3.1 Storage Equipment
7.4.3.2 Sample Analysis Equipment
7.4.3.3 Sample Processing Equipment
7.4.3.4 Sample Transport Equipment
7.5 Consumables
7.5.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
7.5.2 Market Share by Region, 2025 & 2035 (%)
7.5.3 Consumables Segment Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
7.5.3.1 Storage Consumables
7.5.3.2 Analysis Consumables
7.5.3.3 Processing Consumables
7.5.3.4 Collection Consumables
7.6 Services
7.6.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
7.6.2 Market Share by Region, 2025 & 2035 (%)
7.6.3 Services Segment Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
7.6.3.1 Storage Services
7.6.3.2 Processing Services
7.6.3.3 Transport Services
7.6.3.4 Supply Services
7.7 Software
7.7.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
7.7.2 Market Share by Region, 2025 & 2035 (%)

8 Biobanking Market Analysis by Storage Type
8.1 Key Findings
8.2 Storage Type Segment: Market Attractiveness Index
8.3 Biobanking Market Size Estimation and Forecast by Storage Type
8.4 Automated Storage
8.4.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
8.4.2 Market Share by Region, 2025 & 2035 (%)
8.5 Manual Storage
8.5.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
8.5.2 Market Share by Region, 2025 & 2035 (%)

9 Biobanking Market Analysis by End-users
9.1 Key Findings
9.2 End-users Segment: Market Attractiveness Index
9.3 Biobanking Market Size Estimation and Forecast by End-users
9.4 Pharmaceutical & Biotechnology Companies
9.4.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
9.4.2 Market Share by Region, 2025 & 2035 (%)
9.5 CROs
9.5.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
9.5.2 Market Share by Region, 2025 & 2035 (%)
9.6 Academic & Research Institutes
9.6.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
9.6.2 Market Share by Region, 2025 & 2035 (%)
9.7 Hospitals
9.7.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
9.7.2 Market Share by Region, 2025 & 2035 (%)

10 Biobanking Market Analysis by Region
10.1 Key Findings
10.2 Regional Market Size Estimation and Forecast

11 North America Biobanking Market Analysis
11.1 Key Findings
11.2 North America Biobanking Market Attractiveness Index
11.3 North America Biobanking Market by Country, 2025, 2030 & 2035 (US$ Billion)
11.4 North America Biobanking Market Size Estimation and Forecast by Country
11.5 North America Biobanking Market Size Estimation and Forecast by Ownership
11.6 North America Biobanking Market Size Estimation and Forecast by Sample
11.7 North America Biobanking Market Size Estimation and Forecast by Application
11.8 North America Biobanking Market Size Estimation and Forecast by Products and Services
11.9 North America Biobanking Market Size Estimation and Forecast by Storage Type
11.10 North America Biobanking Market Size Estimation and Forecast by End-users
11.11 U.S. Biobanking Market Analysis
11.12 Canada Biobanking Market Analysis

12 Europe Biobanking Market Analysis
12.1 Key Findings
12.2 Europe Biobanking Market Attractiveness Index
12.3 Europe Biobanking Market by Country, 2025, 2030 & 2035 (US$ Billion)
12.4 Europe Biobanking Market Size Estimation and Forecast by Country
12.5 Europe Biobanking Market Size Estimation and Forecast by Ownership
12.6 Europe Biobanking Market Size Estimation and Forecast by Sample
12.7 Europe Biobanking Market Size Estimation and Forecast by Application
12.8 Europe Biobanking Market Size Estimation and Forecast by Products and Services
12.9 Europe Biobanking Market Size Estimation and Forecast by Storage Type
12.10 Europe Biobanking Market Size Estimation and Forecast by End-users
12.11 Germany Biobanking Market Analysis
12.12 UK Biobanking Market Analysis
12.13 France Biobanking Market Analysis
12.14 Italy Biobanking Market Analysis
12.15 Spain Biobanking Market Analysis
12.16 Russia Biobanking Market Analysis
12.17 Rest of Europe Biobanking Market Analysis

13 Asia Pacific Biobanking Market Analysis
13.1 Key Findings
13.2 Asia Pacific Biobanking Market Attractiveness Index
13.3 Asia Pacific Biobanking Market by Country, 2025, 2030 & 2035 (US$ Billion)
13.4 Asia Pacific Biobanking Market Size Estimation and Forecast by Country
13.5 Asia Pacific Biobanking Market Size Estimation and Forecast by Ownership
13.6 Asia Pacific Biobanking Market Size Estimation and Forecast by Sample
13.7 Asia Pacific Biobanking Market Size Estimation and Forecast by Application
13.8 Asia Pacific Biobanking Market Size Estimation and Forecast by Products and Services
13.9 Asia Pacific Biobanking Market Size Estimation and Forecast by Storage Type
13.10 Asia Pacific Biobanking Market Size Estimation and Forecast by End-users
13.11 Japan Biobanking Market Analysis
13.12 China Biobanking Market Analysis
13.13 India Biobanking Market Analysis
13.14 Australia Biobanking Market Analysis
13.15 South Korea Biobanking Market Analysis
13.16 South-East Asia Biobanking Market Analysis
13.17 Rest of Asia Pacific Biobanking Market Analysis

14 Latin America Biobanking Market Analysis
14.1 Key Findings
14.2 Latin America Biobanking Market Attractiveness Index
14.3 Latin America Biobanking Market by Country, 2025, 2030 & 2035 (US$ Billion)
14.4 Latin America Biobanking Market Size Estimation and Forecast by Country
14.5 Latin America Biobanking Market Size Estimation and Forecast by Ownership
14.6 Latin America Biobanking Market Size Estimation and Forecast by Sample
14.7 Latin America Biobanking Market Size Estimation and Forecast by Application
14.8 Latin America Biobanking Market Size Estimation and Forecast by Products and Services
14.9 Latin America Biobanking Market Size Estimation and Forecast by Storage Type
14.10 Latin America Biobanking Market Size Estimation and Forecast by End-users
14.11 Brazil Biobanking Market Analysis
14.12 Mexico Biobanking Market Analysis
14.13 Rest of Latin America Biobanking Market Analysis

15 MEA Biobanking Market Analysis
15.1 Key Findings
15.2 MEA Biobanking Market Attractiveness Index
15.3 MEA Biobanking Market by Country, 2025, 2030 & 2035 (US$ Billion)
15.4 MEA Biobanking Market Size Estimation and Forecast by Country
15.5 MEA Biobanking Market Size Estimation and Forecast by Ownership
15.6 MEA Biobanking Market Size Estimation and Forecast by Sample
15.7 MEA Biobanking Market Size Estimation and Forecast by Application
15.8 MEA Biobanking Market Size Estimation and Forecast by Products and Services
15.9 MEA Biobanking Market Size Estimation and Forecast by Storage Type
15.10 MEA Biobanking Market Size Estimation and Forecast by End-users
15.11 GCC Biobanking Market Analysis
15.12 South Africa Biobanking Market Analysis
15.13 Rest of MEA Biobanking Market Analysis

16 Company Profiles
16.1 Thermo Fisher Scientific Inc.
16.1.1 Company Snapshot
16.1.2 Company Overview
16.1.3 Financial Analysis
16.1.3.1 Net Revenue, 2020-2024
16.1.3.2 Regional Market Shares, 2024
16.1.3.3 R&D, 2020-2024
16.1.4 Product Benchmarking
16.2 PHC Holdings Corporation
16.2.1 Company Snapshot
16.2.2 Company Overview
16.2.3 Product Benchmarking
16.2.4 Strategic Outlook
16.3 Hamilton Company
16.3.1 Company Snapshot
16.3.2 Company Overview
16.3.3 Product Benchmarking
16.4 Avantor Inc.
16.4.1 Company Snapshot
16.4.2 Company Overview
16.4.3 Financial Analysis
16.4.3.1 Net Revenue, 2020-2024
16.4.3.2 Regional Market Shares, 2024
16.4.4 Product Benchmarking
16.5 QIAGEN
16.5.1 Company Snapshot
16.5.2 Company Overview
16.5.3 Financial Analysis
16.5.3.1 Net Revenue, 2020-2024
16.5.3.2 Regional Market Shares, 2024
16.5.3.3 R&D, 2020-2024
16.5.4 Product Benchmarking
16.6 Tecan Trading AG
16.6.1 Company Snapshot
16.6.2 Company Overview
16.6.3 Product Benchmarking
16.7 Merck KGaA
16.7.1 Company Snapshot
16.7.2 Company Overview
16.7.3 Financial Analysis
16.7.3.1 Net Revenue, 2020-2024
16.7.3.2 Regional Market Shares, 2024
16.7.3.3 R&D, 2020-2024
16.7.4 Product Benchmarking
16.8 Cryoport, Inc.
16.8.1 Company Snapshot
16.8.2 Company Overview
16.8.3 Financial Analysis
16.8.3.1 Net Revenue, 2020-2024
16.8.3.2 Regional Market Shares, 2024
16.8.3.3 R&D, 2020-2024
16.8.4 Product Benchmarking
16.8.5 Strategic Outlook
16.9 Azenta Inc.
16.9.1 Company Snapshot
16.9.2 Company Overview
16.9.3 Financial Analysis
16.9.3.1 Net Revenue, 2020-2024
16.9.3.2 R&D, 2020-2024
16.9.4 Product Benchmarking
16.10 ISENET
16.10.1 Company Snapshot
16.10.2 Company Overview
16.10.3 Product Benchmarking
16.11 CTIBiotech
16.11.1 Company Snapshot
16.11.2 Company Overview
16.11.3 Product Benchmarking
16.12 Boca Biolistics
16.12.1 Company Snapshot
16.12.2 Company Overview
16.12.3 Product Benchmarking
16.12.4 Strategic Outlook
16.13 BIOIVT
16.13.1 Company Snapshot
16.13.2 Company Overview
16.13.3 Product Benchmarking
16.13.4 Strategic Outlook
16.14 US Biolab Corporation
16.14.1 Company Snapshot
16.14.2 Company Overview
16.14.3 Product Benchmarking
16.15 ProteoGenex Inc.
16.15.1 Company Snapshot
16.15.2 Company Overview
16.15.3 Product Benchmarking
16.16 ASKION GmbH
16.16.1 Company Snapshot
16.16.2 Company Overview
16.16.3 Product Benchmarking
16.17 STEMCELL Technologies
16.17.1 Company Snapshot
16.17.2 Company Overview
16.17.3 Product Benchmarking
16.17.4 Strategic Outlook
16.18 SciSafe
16.18.1 Company Snapshot
16.18.2 Company Overview
16.18.3 Product Benchmarking
16.19 Charles River Laboratories International, Inc.
16.19.1 Company Snapshot
16.19.2 Company Overview
16.19.3 Financial Analysis
16.19.3.1 Net Revenue, 2020-2024
16.19.3.2 Regional Market Shares, 2024
16.19.4 Product Benchmarking
16.19.5 Strategic Outlook
16.20 BD
16.20.1 Company Snapshot
16.20.2 Company Overview
16.20.3 Financial Analysis
16.20.3.1 Net Revenue, 2020-2024
16.20.3.2 Regional Market Shares, 2024
16.20.3.3 R&D, 2020-2024
16.20.4 Product Benchmarking
16.21 Labcorp
16.21.1 Company Snapshot
16.21.2 Company Overview
16.21.3 Financial Analysis
16.21.3.1 Net Revenue, 2020-2024
16.21.3.2 Regional Market Shares, 2024
16.21.4 Product Benchmarking

17 Conclusion and Recommendations
17.1 Concluding Remarks from Visiongain
17.2 Recommendations for Market Players

 

ページTOPに戻る



List of Tables/Graphs

List of Tables
Table 1 Biobanking Market Snapshot, 2025 & 2035 (US$ Billion, CAGR %)
Table 2 Biobanking Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 3 Biobanking Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%): U Shaped Recovery
Table 4 Biobanking Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%): L Shaped Recovery
Table 5 Biobanking Market Forecast by Ownership, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 6 National/ Regional Agencies Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 7 Universities Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 8 Non-profit Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 9 Private Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 10 Biobanking Market Forecast by Sample, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 11 Blood Products Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 12 Human Tissues Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 13 Nucleic Acid Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 14 Cell Lines Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 15 Biological Fluids Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 16 Others Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 17 Biobanking Market Forecast by Application, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 18 Regenerative Medicine Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 19 Life Science Research Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 20 Clinical Research Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 21 Biobanking Market Forecast by Products and Services, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 22 Equipment Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 23 Biobanking Market Forecast by Products and Services, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 24 Consumables Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 25 Biobanking Market Forecast by Products and Services, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 26 Services Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 27 Biobanking Market Forecast by Products and Services, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 28 Software Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 29 Biobanking Market Forecast by Application, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 30 Automated Storage Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 31 Manual Storage Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 32 Biobanking Market Forecast by End-users, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 33 Pharmaceutical & Biotechnology Companies Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 34 CROs Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 35 Academic & Research Institutes Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 36 Hospitals Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 37 Biobanking Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 38 North America Biobanking Market Forecast by Country, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 39 North America Biobanking Market Forecast by Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 40 North America Biobanking Market Forecast by Sample, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 41 North America Biobanking Market Forecast by Application, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 42 North America Biobanking Market Forecast by Products and Services, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 43 North America Biobanking Market Forecast by Country, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 44 North America Biobanking Market Forecast by End-users, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 45 U.S. Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 46 Canada Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 47 Europe Biobanking Market Forecast by Country, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 48 Europe Biobanking Market Forecast by Ownership, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 49 Europe Biobanking Market Forecast by Sample, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 50 Europe Biobanking Market Forecast by Application, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 51 Europe Biobanking Market Forecast by Products and Services, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 52 Europe Biobanking Market Forecast by Country, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 53 Europe Biobanking Market Forecast by End-users, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 54 Germany Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 55 UK Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 56 France Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 57 Italy Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 58 Spain Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 59 Russia Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 60 Rest of Europe Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 61 Asia Pacific Biobanking Market Forecast by Country, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 62 Asia Pacific Biobanking Market Forecast by Ownership, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 63 Asia Pacific Biobanking Market Forecast by Sample, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 64 Asia Pacific Biobanking Market Forecast by Application, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 65 Asia Pacific Biobanking Market Forecast by Products and Services, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 66 Asia Pacific Biobanking Market Forecast by Country, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 67 Asia Pacific Biobanking Market Forecast by End-users, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 68 Japan Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 69 China Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 70 India Biobanking Institutes
Table 71 India Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 72 Australia Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 73 South Korea Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 74 South-East Asia Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 75 Rest of Asia Pacific Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 76 Latin America Biobanking Market Forecast by Country, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 77 Latin America Biobanking Market Forecast by Ownership, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 78 Latin America Biobanking Market Forecast by Sample, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 79 Latin America Biobanking Market Forecast by Application, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 80 Latin America Biobanking Market Forecast by Products and Services, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 81 Latin America Biobanking Market Forecast by Country, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 82 Latin America Biobanking Market Forecast by End-users, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 83 Brazil Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 84 Mexico Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 85 Rest of Latin America Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 86 MEA Biobanking Market Forecast by Country, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 87 MEA Biobanking Market Forecast by Ownership, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 88 MEA Biobanking Market Forecast by Sample, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 89 MEA Biobanking Market Forecast by Application, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 90 MEA Biobanking Market Forecast by Products and Services, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 91 MEA Biobanking Market Forecast by Country, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 92 MEA Biobanking Market Forecast by End-users, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 93 GCC Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 94 South Africa Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 95 Rest of MEA Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 96 Thermo Fisher Scientific Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 97 Thermo Fisher Scientific Inc.: Product Benchmarking
Table 98 PHC Holdings Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 99 PHC Holdings Corporation: Product Benchmarking
Table 100 PHC Holdings Corporation: Strategic Outlook
Table 101 Hamilton Company: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 102 Hamilton Company: Product Benchmarking
Table 103 Avantor Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 104 Avantor Inc.: Product Benchmarking
Table 105 QIAGEN: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 106 QIAGEN: Product Benchmarking
Table 107 Tecan Trading AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 108 Tecan Trading AG: Product Benchmarking
Table 109 Merck KGaA: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 110 Merck KGaA: Product Benchmarking
Table 111 Cryoport, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 112 Cryoport, Inc.: Product Benchmarking
Table 113 Cryoport, Inc.: Strategic Outlook
Table 114 Azenta Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 115 Azenta Inc.: Product Benchmarking
Table 116 ISENET: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 117 ISENET: Product Benchmarking
Table 118 CTIBiotech: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 119 CTIBiotech: Product Benchmarking
Table 120 Boca Biolistics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 121 Boca Biolistics: Product Benchmarking
Table 122 Boca Biolistics: Strategic Outlook
Table 123 BIOIVT: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 124 BIOIVT: Product Benchmarking
Table 125 BIOIVT: Strategic Outlook
Table 126 US Biolab Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 127 US Biolab Corporation: Product Benchmarking
Table 128 ProteoGenex Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 129 ProteoGenex Inc.: Product Benchmarking
Table 130 ASKION GmbH: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 131 ASKION GmbH: Product Benchmarking
Table 132 STEMCELL Technologies: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 133 STEMCELL Technologies: Product Benchmarking
Table 134 STEMCELL Technologies: Strategic Outlook
Table 135 SciSafe: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 136 SciSafe: Product Benchmarking
Table 137 Charles River Laboratories International, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 138 Charles River Laboratories International, Inc.: Product Benchmarking
Table 139 Charles River Laboratories International, Inc.: Strategic Outlook
Table 140 BD: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 141 BD: Product Benchmarking
Table 142 Labcorp: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 143 Labcorp: Product Benchmarking
 
List of Figures
Figure 1 Biobanking Market Segmentation
Figure 2 Biobanking Market by Ownership: Market Attractiveness Index
Figure 3 Biobanking Market by Sample: Market Attractiveness Index
Figure 4 Biobanking Market by Application: Market Attractiveness Index
Figure 5 Biobanking Market by Products and Services: Market Attractiveness Index
Figure 6 Biobanking Market by End-users: Market Attractiveness Index
Figure 7 Biobanking Market Attractiveness Index by Region
Figure 8 Biobanking Market: Market Dynamics
Figure 1 Biobanking Market by Region, 2025-2035 (US$ Billion, AGR %), Tariff Impact: V-Shaped Recovery Scenario
Figure 2 Biobanking Market by Region, 2025-2035 (US$ Billion, AGR %), Tariff Impact: U-Shaped Recovery Scenario
Figure 3 Biobanking Market by Region, 2025-2035 (US$ Billion, AGR %), Tariff Impact: L-Shaped Recovery Scenario
Figure 4 Short Term & Long Term Planning
Figure 5 Impact of U.S. and China Trade War
Figure 6 Most Impacted Countries
Figure 7 Biobanking Market: Porter’s Five Forces Analysis
Figure 8 Biobanking Market: PEST Analysis
Figure 9 Biobanking Market Attractiveness Index by Ownership
Figure 10 Biobanking Market Forecast by Ownership, 2025-2035 (US$ Billion, AGR %)
Figure 11 Biobanking Market Share Forecast by Ownership, 2025, 2030, 2035 (%)
Figure 12 National/Regional Agencies Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 13 National/Regional Agencies Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 14 Universities Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 15 Universities Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 16 Non-profit Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 17 Non-profit Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 18 Private Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 19 Private Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 20 Biobanking Market Attractiveness Index by Ownership
Figure 21 Biobanking Market Forecast by Sample, 2025-2035 (US$ Billion, AGR %)
Figure 22 Biobanking Market Share Forecast by Sample, 2025, 2030, 2035 (%)
Figure 23 Blood Products Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 24 Blood Products Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 25 Human Tissues Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 26 Human Tissues Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 27 Nucleic Acids Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 28 Nucleic Acids Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 29 Cell Lines Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 30 Cell Lines Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 31 Biological Fluids Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 32 Biological Fluids Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 33 Others Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 34 Others Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 35 Biobanking Market Attractiveness Index by Application
Figure 36 Biobanking Market Forecast by Application, 2025-2035 (US$ Billion, AGR %)
Figure 37 Biobanking Market Share Forecast by Application, 2025, 2030, 2035 (%)
Figure 38 Regenerative Medicine Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 39 Regenerative Medicine Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 40 Life Science Research Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 41 Life Science Research Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 42 Clinical Research Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 43 Clinical Research Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 44 Biobanking Market Attractiveness Index by Products and Services
Figure 45 Biobanking Market Forecast by Products and Services, 2025-2035 (US$ Billion, AGR %)
Figure 46 Biobanking Market Share Forecast by Products and Services, 2025, 2030, 2035 (%)
Figure 47 Equipment Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 48 Equipment Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 49 Equipment Segment Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
Figure 50 Consumables Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 51 Consumables Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 52 Consumables Segment Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
Figure 53 Services Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 54 Services Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 55 Services Segment Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
Figure 56 Software Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 57 Software Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 58 Biobanking Market Attractiveness Index by Storage Type
Figure 59 Biobanking Market Forecast by Storage Type, 2025-2035 (US$ Billion, AGR %)
Figure 60 Biobanking Market Share Forecast by Storage Type, 2025, 2030, 2035 (%)
Figure 61 Automated Storage Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 62 Automated Storage Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 63 Manual Storage Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 64 Manual Storage Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 65 Biobanking Market Attractiveness Index by End-users
Figure 66 Biobanking Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %)
Figure 67 Biobanking Market Share Forecast by End-users, 2025, 2030, 2035 (%)
Figure 68 Pharmaceutical & Biotechnology Companies Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 69 Pharmaceutical & Biotechnology Companies Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 70 CROs Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 71 CROs Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 72 Academic & Research Institutes Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 73 Academic & Research Institutes Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 74 Hospitals Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 75 Hospitals Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 76 Biobanking Market Forecast by Region 2025, 2030, 2035 (Revenue, CAGR%)
Figure 77 Biobanking Market Share Forecast by Region 2025, 2030, 2035 (%)
Figure 78 Biobanking Market by Region, 2025-2035 (US$ Billion, AGR %)
Figure 79 North America Biobanking Market Attractiveness Index
Figure 80 North America Biobanking Market by Region, 2025, 2030 & 2035 (US$ Billion)
Figure 81 North America Biobanking Market Forecast by Country, 2025-2035 (US$ Billion)
Figure 82 North America Biobanking Market Share Forecast by Country, 2025 & 2035 (%)
Figure 83 North America Biobanking Market Forecast by Ownership, 2025-2035 (US$ Billion, AGR %)
Figure 84 North America Biobanking Market Share Forecast by Ownership, 2025 & 2035 (%)
Figure 85 North America Biobanking Market Forecast by Sample, 2025-2035 (US$ Billion, AGR %)
Figure 86 North America Biobanking Market Share Forecast by Sample, 2025 & 2035 (%)
Figure 87 North America Biobanking Market Forecast by Application, 2025-2035 (US$ Billion, AGR %)
Figure 88 North America Biobanking Market Share Forecast by Application, 2025 & 2035 (%)
Figure 89 North America Biobanking Market Forecast by Products and Services, 2025-2035 (US$ Billion, AGR %)
Figure 90 North America Biobanking Market Share Forecast by Products and Services, 2025 & 2035 (%)
Figure 91 North America Biobanking Market Forecast by Storage Type, 2025-2035 (US$ Billion, AGR %)
Figure 92 North America Biobanking Market Share Forecast by Storage Type, 2025 & 2035 (%)
Figure 93 North America Biobanking Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %)
Figure 94 North America Biobanking Market Share Forecast by End-users, 2025 & 2035 (%)
Figure 95 U.S. Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 96 Canada Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 97 Europe Biobanking Market Attractiveness Index
Figure 98 Europe Biobanking Market by Region, 2025, 2030 & 2035 (US$ Billion)
Figure 99 Europe Biobanking Market Forecast by Country, 2025-2035 (US$ Billion)
Figure 100 Europe Biobanking Market Share Forecast by Country, 2025 & 2035 (%)
Figure 101 Europe Biobanking Market Forecast by Ownership, 2025-2035 (US$ Billion, AGR %)
Figure 102 Europe Biobanking Market Share Forecast by Ownership, 2025 & 2035 (%)
Figure 103 Europe Biobanking Market Forecast by Sample, 2025-2035 (US$ Billion, AGR %)
Figure 104 Europe Biobanking Market Share Forecast by Sample, 2025 & 2035 (%)
Figure 105 Europe Biobanking Market Forecast by Application, 2025-2035 (US$ Billion, AGR %)
Figure 106 Europe Biobanking Market Share Forecast by Application, 2025 & 2035 (%)
Figure 107 Europe Biobanking Market Forecast by Products and Services, 2025-2035 (US$ Billion, AGR %)
Figure 108 Europe Biobanking Market Share Forecast by Products and Services, 2025 & 2035 (%)
Figure 109 Europe Biobanking Market Forecast by Storage Type, 2025-2035 (US$ Billion, AGR %)
Figure 110 Europe Biobanking Market Share Forecast by Storage Type, 2025 & 2035 (%)
Figure 111 Europe Biobanking Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %)
Figure 112 Europe Biobanking Market Share Forecast by End-users, 2025 & 2035 (%)
Figure 113 Germany Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 114 UK Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 115 France Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 116 Italy Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 117 Spain Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 118 Russia Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 119 Rest of Europe Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 120 Asia Pacific Biobanking Market Attractiveness Index
Figure 121 Asia Pacific Biobanking Market by Region, 2025, 2030 & 2035 (US$ Billion)
Figure 122 Asia Pacific Biobanking Market Forecast by Country, 2025-2035 (US$ Billion)
Figure 123 Asia Pacific Biobanking Market Share Forecast by Country, 2025 & 2035 (%)
Figure 124 Asia Pacific Biobanking Market Forecast by Ownership, 2025-2035 (US$ Billion, AGR %)
Figure 125 Asia Pacific Biobanking Market Share Forecast by Ownership, 2025 & 2035 (%)
Figure 126 Asia Pacific Biobanking Market Forecast by Sample, 2025-2035 (US$ Billion, AGR %)
Figure 127 Asia Pacific Biobanking Market Share Forecast by Sample, 2025 & 2035 (%)
Figure 128 Asia Pacific Biobanking Market Forecast by Application, 2025-2035 (US$ Billion, AGR %)
Figure 129 Asia Pacific Biobanking Market Share Forecast by Application, 2025 & 2035 (%)
Figure 130 Asia Pacific Biobanking Market Forecast by Products and Services, 2025-2035 (US$ Billion, AGR %)
Figure 131 Asia Pacific Biobanking Market Share Forecast by Products and Services, 2025 & 2035 (%)
Figure 132 Asia Pacific Biobanking Market Forecast by Storage Type, 2025-2035 (US$ Billion, AGR %)
Figure 133 Asia Pacific Biobanking Market Share Forecast by Storage Type, 2025 & 2035 (%)
Figure 134 Asia Pacific Biobanking Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %)
Figure 135 Asia Pacific Biobanking Market Share Forecast by End-users, 2025 & 2035 (%)
Figure 136 Japan Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 137 China Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 138 India Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 139 Australia Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 140 South Korea Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 141 South-East Asia Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 142 Rest of Asia Pacific Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 143 Latin America Biobanking Market Attractiveness Index
Figure 144 Latin America Biobanking Market by Region, 2025, 2030 & 2035 (US$ Billion)
Figure 145 Latin America Biobanking Market Forecast by Country, 2025-2035 (US$ Billion)
Figure 146 Latin America Biobanking Market Share Forecast by Country, 2025 & 2035 (%)
Figure 147 Latin America Biobanking Market Forecast by Ownership, 2025-2035 (US$ Billion, AGR %)
Figure 148 Latin America Biobanking Market Share Forecast by Ownership, 2025 & 2035 (%)
Figure 149 Latin America Biobanking Market Forecast by Sample, 2025-2035 (US$ Billion, AGR %)
Figure 150 Latin America Biobanking Market Share Forecast by Sample, 2025 & 2035 (%)
Figure 151 Latin America Biobanking Market Forecast by Application, 2025-2035 (US$ Billion, AGR %)
Figure 152 Latin America Biobanking Market Share Forecast by Application, 2025 & 2035 (%)
Figure 153 Latin America Biobanking Market Forecast by Products and Services, 2025-2035 (US$ Billion, AGR %)
Figure 154 Latin America Biobanking Market Share Forecast by Products and Services, 2025 & 2035 (%)
Figure 155 Latin America Biobanking Market Forecast by Storage Type, 2025-2035 (US$ Billion, AGR %)
Figure 156 Latin America Biobanking Market Share Forecast by Storage Type, 2025 & 2035 (%)
Figure 157 Latin America Biobanking Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %)
Figure 158 Latin America Biobanking Market Share Forecast by End-users, 2025 & 2035 (%)
Figure 159 Brazil Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 160 Mexico Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 161 Rest of Latin America Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 162 MEA Biobanking Market Attractiveness Index
Figure 163 MEA Biobanking Market by Region, 2025, 2030 & 2035 (US$ Billion)
Figure 164 MEA Biobanking Market Forecast by Country, 2025-2035 (US$ Billion)
Figure 165 MEA Biobanking Market Share Forecast by Country, 2025 & 2035 (%)
Figure 166 MEA Biobanking Market Forecast by Ownership, 2025-2035 (US$ Billion, AGR %)
Figure 167 MEA Biobanking Market Share Forecast by Ownership, 2025 & 2035 (%)
Figure 168 MEA Biobanking Market Forecast by Sample, 2025-2035 (US$ Billion, AGR %)
Figure 169 MEA Biobanking Market Share Forecast by Sample, 2025 & 2035 (%)
Figure 170 MEA Biobanking Market Forecast by Application, 2025-2035 (US$ Billion, AGR %)
Figure 171 MEA Biobanking Market Share Forecast by Application, 2025 & 2035 (%)
Figure 172 MEA Biobanking Market Forecast by Products and Services, 2025-2035 (US$ Billion, AGR %)
Figure 173 MEA Biobanking Market Share Forecast by Products and Services, 2025 & 2035 (%)
Figure 174 MEA Biobanking Market Forecast by Storage Type, 2025-2035 (US$ Billion, AGR %)
Figure 175 MEA Biobanking Market Share Forecast by Storage Type, 2025 & 2035 (%)
Figure 176 MEA Biobanking Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %)
Figure 177 MEA Biobanking Market Share Forecast by End-users, 2025 & 2035 (%)
Figure 178 GCC Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 179 South Africa Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 180 Rest of MEA Biobanking Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 181 Thermo Fisher Scientific Inc.: Net Revenue, 2020-2024 (US$ Million, AGR%)
Figure 182 Thermo Fisher Scientific Inc.: Regional Market Shares (%), 2024
Figure 183 Thermo Fisher Scientific Inc.: R&D, 2020-2024 (US$ Million, AGR%)
Figure 184 Avantor Inc.: Net Revenue, 2020-2024 (US$ Million, AGR%)
Figure 185 Avantor Inc.: Regional Market Shares (%), 2024
Figure 186 QIAGEN: Net Revenue, 2020-2024 (US$ Million, AGR%)
Figure 187 QIAGEN: Regional Market Shares (%), 2024
Figure 188 QIAGEN: R&D, 2020-2024 (US$ Million, AGR%)
Figure 189 Merck KGaA: Net Revenue, 2020-2024 (US$ Million, AGR%)
Figure 190 Merck KGaA: Regional Market Shares (%), 2024
Figure 191 Merck KGaA: R&D, 2020-2024 (US$ Million, AGR%)
Figure 192 Cryoport, Inc.: Net Revenue, 2020-2024 (US$ Million, AGR%)
Figure 193 Cryoport, Inc.: Regional Market Shares (%), 2024
Figure 194 Cryoport, Inc.: R&D, 2020-2024 (US$ Million, AGR%)
Figure 195 Azenta Inc.: Net Revenue, 2020-2024 (US$ Million, AGR%)
Figure 196 Azenta Inc.: R&D, 2020-2024 (US$ Million, AGR%)
Figure 197 Charles River Laboratories International, Inc.: Net Revenue, 2020-2024 (US$ Million, AGR%)
Figure 198 Charles River Laboratories International, Inc.: Regional Market Shares (%), 2024
Figure 199 BD: Net Revenue, 2020-2024 (US$ Million, AGR%)
Figure 200 BD: Regional Market Shares (%), 2024
Figure 201 BD: R&D, 2020-2024 (US$ Million, AGR%)
Figure 202 Labcorp: Net Revenue, 2020-2024 (US$ Million, AGR%)
Figure 203 Labcorp: Regional Market Shares (%), 2024

　

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（抗感染性薬物）の最新刊レポート

Visiongain社の ヘルスケアと医薬・化学品分野 での最新刊レポート

本レポートと同じKEY WORD（）の最新刊レポート

  • 本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問


Visiongain社はどのような調査会社ですか?


英国の調査会社ヴィジョンゲイン社（Visiongain）は、通信とエネルギーのほか、自動車や化学・医薬品、金属など、広範な市場を対象に調査を行っています。自動車市場については、市場全般に関する調査のほ... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。


詳細検索

このレポートへのお問合せ

お問合せはこちらから

03-3582-2531

電話お問合せもお気軽に

 

当社ご利用のメリット
  1. ① お探しの情報に合わせてレポートをご紹介
  2. ② レポートで不足している情報はカスタマイズで対応可能
  3. ③ 特許情報、海外の法規制の取り組みなどディープな調査も対応可能
  4. ④ 円貨で請求書払い＆万全のアフターフォロー

 

2025/12/04　10:26

156.30 円

182.61 円

211.19 円

ページTOPに戻る

株式会社 データリソース　Data Resource, Inc.
東京都千代田区丸の内3-3-1 新東京ビル4F 430


A member of CORSS Business Producers Inc.
データリソースは2025年5月より
CROSS Business Producers株式会社 の100%子会社になりました。

電話：03-3582-2531
FAX：03-6551-2556
Eメール：office@dri.co.jp

会社概要 FAQ サイトマップ プライバシーポリシー お問合せ

関連会社:
株式会社ユーディーアール

COPYRIGHT(C) 2011-2025　DATA RESOURCE, Inc. ALL RIGHTS RESERVED.